Nantong Jinghua Pharmaceutical Co Ltd (002349) — Cash Flow Reinvestment Rate
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Cash Flow Reinvestment Rate of 0.05x as of September 2025, reinvesting CN¥4.62 Million (capex CN¥4.62 Million ) from operating cash flow of CN¥97.93 Million. See how much free cash does Nantong Jinghua Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nantong Jinghua Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Nantong Jinghua Pharmaceutical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Nantong Jinghua Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Nantong Jinghua Pharmaceutical Co Ltd. See Nantong Jinghua Pharmaceutical Co Ltd (002349) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CN¥339.26 Million | CN¥340.87 Million | CN¥20.32 Million | ▲ +18.7% |
| 2024 | 0.84x | CN¥260.87 Million | CN¥311.02 Million | CN¥30.92 Million | ▲ +15.0% |
| 2023 | 0.73x | CN¥212.49 Million | CN¥291.31 Million | CN¥28.38 Million | ▲ +71.2% |
| 2022 | 0.43x | CN¥152.68 Million | CN¥358.39 Million | CN¥61.59 Million | ▲ +53.4% |
| 2021 | 0.28x | CN¥84.87 Million | CN¥305.57 Million | CN¥80.55 Million | ▼ -54.2% |
| 2020 | 0.61x | CN¥198.88 Million | CN¥328.22 Million | CN¥118.46 Million | ▼ -34.0% |
| 2019 | 0.92x | CN¥261.97 Million | CN¥285.38 Million | CN¥255.35 Million | ▼ -52.2% |
| 2018 | 1.92x | CN¥160.33 Million | CN¥83.43 Million | CN¥160.25 Million | ▼ -66.9% |
| 2017 | 5.81x | CN¥441.18 Million | CN¥75.92 Million | CN¥441.17 Million | ▲ +257.2% |
| 2016 | 1.63x | CN¥559.24 Million | CN¥343.80 Million | CN¥245.10 Million | ▲ +157.8% |
| 2014 | 0.63x | CN¥28.83 Million | CN¥45.70 Million | CN¥28.83 Million | ▼ -74.4% |
| 2012 | 2.46x | CN¥190.26 Million | CN¥77.25 Million | CN¥190.26 Million | ▲ +1.2% |
| 2011 | 2.43x | CN¥100.89 Million | CN¥41.45 Million | CN¥100.89 Million | ▲ +178.5% |
| 2010 | 0.87x | CN¥35.89 Million | CN¥41.06 Million | CN¥35.89 Million | ▲ +1046.7% |
| 2009 | 0.08x | CN¥4.40 Million | CN¥57.76 Million | CN¥4.40 Million | ▼ -44.7% |
| 2008 | 0.14x | CN¥2.36 Million | CN¥17.13 Million | CN¥2.36 Million | ▲ +5.1% |
| 2007 | 0.13x | CN¥4.44 Million | CN¥33.86 Million | CN¥4.44 Million | ▼ -1.4% |
| 2006 | 0.13x | CN¥2.95 Million | CN¥22.18 Million | CN¥2.95 Million | — |